MedPath

Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy

Not Applicable
Completed
Conditions
Colorectal Adenomas
Colorectal Polyps
Interventions
Device: Arc Endocuff (AEC 110, 120, 130, 140)
Device: Cap
Device: Standard colonoscope
Registration Number
NCT02331836
Lead Sponsor
Helios Albert-Schweitzer-Klinik Northeim
Brief Summary

Comparison of Endocuff-assisted, Cap-assisted and Standard colonoscopy for assessment of the adenoma detection rate (ADR)

Detailed Description

The Endocuff is a medical device, approved in 2012 by the American Food and Drug Administration, which was also authorized by the European Agency for the Evaluation of Medicinal Products. The aim of the cuff is to optimize the view of the colonic mucosa. There is also a transparent cap on the market, which is used in colonoscopy for a better evaluation of the mucosa and polyp detection. The goal of this project is to conduct a prospective randomized trial for clarification of the hypotheses, whether the usage of the Endocuff increases the detection rate of adenomas compared to the transparent cap or compared to standard colonoscopy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
561
Inclusion Criteria
  • Colonoscopy independent from indication
  • Age ≥ 18
  • Patient is able to provide informed consent for the procedure
Exclusion Criteria
  • Inflammatory Bowel Disease stenosis
  • Pregnant of nursing patient
  • Acute diverticulitis
  • Active Inflammatory Bowel Disease
  • Age ≤ 18
  • Coagulation disorder (INR>1.4 , Thrombocytes < 50000/µl)

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Arc Endocuff (AEC 110, 120, 130, 140)Arc Endocuff (AEC 110, 120, 130, 140)Endocuff-assisted colonoscopy Colonoscopy with the Endocuff attached at the distal tip of the scope
CapCapCap-assisted colonoscopy Colonoscopy with the transparent Cap attached at the distal tip of the scope
Standard ColonoscopeStandard colonoscopeStandard colonoscopy without any additional device
Primary Outcome Measures
NameTimeMethod
Adenoma detection rate1 year

Proportion of patients having at least one adenoma

Polyp detection rate1 year

Proportion of patients having at least one adenoma

Secondary Outcome Measures
NameTimeMethod
perforationone day
Ileum intubation rateone year
withdrawal timeone day
mucosal lacerationone day
severe bleedingone day
Bowel preparation resultone day
Coecum intubation rateone year
Coecum intubation timeone day

Trial Locations

Locations (6)

University Medical Center Göttingen

🇩🇪

Göttingen, Germany

HELIOS St. Marienberg Klinik Helmstedt

🇩🇪

Helmstedt, Germany

University of Muenster

🇩🇪

Muenster, North-Rhine Westphalia, Germany

HELIOS Albert-Schweitzer-Klinik

🇩🇪

Northeim, Germany

HELIOS Medical Center Siegburg

🇩🇪

Siegburg, Germany

Wroclaw Medical University

🇵🇱

Wroclaw, Poland

© Copyright 2025. All Rights Reserved by MedPath